Revenue decreased 2.2%
Revenue changed -2.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -2.2% from the comparable as-filed period.
Cash & equivalents changed -30.4% from the comparable as-filed period.
Debt changed -40.0% from the comparable as-filed period.
Gross margin changed -470 basis points from the comparable as-filed period.
Gross profit changed -28.4% from the comparable as-filed period.
Net income changed -19340.0% from the comparable as-filed period.
Operating income changed -11914.3% from the comparable as-filed period.
Operating margin changed -4999 basis points from the comparable as-filed period.
Selling, general & administrative changed -29.2% from the comparable as-filed period.
Research & development changed -18.2% from the comparable as-filed period.
Inventory changed -4.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.